0001127602-22-019824.txt : 20220727 0001127602-22-019824.hdr.sgml : 20220727 20220727193803 ACCESSION NUMBER: 0001127602-22-019824 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220725 FILED AS OF DATE: 20220727 DATE AS OF CHANGE: 20220727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ACKERMANN CHRISTINA CENTRAL INDEX KEY: 0001681871 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41380 FILM NUMBER: 221112343 MAIL ADDRESS: STREET 1: C/O BLCO STREET 2: 400 SOMERSET CORPORATE BLVD. CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch & Lomb Corp CENTRAL INDEX KEY: 0001860742 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 520 APPLEWOOD CRESCENT CITY: VAUGHAN STATE: A6 ZIP: L4K 4B4 BUSINESS PHONE: 908-541-5456 MAIL ADDRESS: STREET 1: 520 APPLEWOOD CRESCENT CITY: VAUGHAN STATE: A6 ZIP: L4K 4B4 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-07-25 0001860742 Bausch & Lomb Corp BLCO 0001681871 ACKERMANN CHRISTINA C/O BAUSCH + LOMB CORPORATION 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K4B4 ONTARIO, CANADA 1 Please see remarks Common Shares, No Par Value 2022-07-25 4 A 0 35000 0 A 118333 D Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. The Reporting Person's title as an officer of the Issuer is Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals. /s/ Debra E. Levin, attorney-in-fact 2022-07-27